Serum amyloid A (SAA) is a sensitive acute phase protein; its serum level can increase from its normal concentration by up to 1000-fold. Although a series of recent studies have indicated the clinical usefulness of monitoring SAA in several inflammatory disorders, I SAA does not appear to be widely measured in the clinical laboratories. One reason for its limited availability is the absence of methods which can be performed by automated analysers used for multiple biochemical tests. We have described a latex agglutination nephelometric immunoassay (LA assay) for measuring SAA concentration in serum.! However, the method can be performed only with a limited number of analysers. We have therefore modified the latex reagents and assay conditions so that SAA assays can be performed by commonly used automated analysers.
A Hitachi 7070 analyser was used for this work, it does not have a pre-dilution function, thus prozone phenomenon may occur at high levels of SAA. To avoid this problem, anti-SA A monoclonal and polyclonal antibody-coated latex particles were used. The latex reagents were prepared from rabbit polyclonal antibodies? or murine monoclonal antibody and polystyrene latex particles of mean diameter; 0·1 /lm, at concentrations of 2·6 giL and 20 g/L, respectively, were mixed in 0·1 M HEPES buffer, pH 7-4 for 60min at 37"C. After being washed by centrifugation, the latex particles were suspended at 0·4% in 5 mM HEPES buffer. The latex reagent used for the assay consists of 4 volumes of polyclonal antibody-conjugate and one of monoclonal antibody-conjugate. Three microlitres of sample was mixed with 225/lL of HEPES buffer containing 5 giL bovine serum albumin, 10 g/L horse serum and 120 giL choline chloride and was incubated with 75/lL of the latex reagent at 3TC. The change in turbidity at 660 nm after a 4 min incubation was used to determine the SAA concentration. The same assay standard (SAA-rich high density lipoproteins) as described in the previous LA assay," six levels of SAA (0, 12, 5, 25, 50, 100 Ann Clin Biochem 1997; 34: 569-574 and 200 mg/l.) was used to derive calibration curves.
The coefficient of variation is given in Table 1 . The recovery of SAA was 100%,96% and 100% when 6·3 mg/L, 13 mg/L and 50 rng/L of SAA was added to a serum sample with SAA value of 12mg/L.
Replicate analysis (n = 10) of the zero standard demonstrated the detection limit to be 5·0 mg/L (mean + 2 SO).
Interference studies indicated that haemoglobin, bilirubin and rheumatoid factor did not affect measurement up to 5 giL, 200 mg/L and 1000 IU/mL, respectively. 
Difference versus mean plots
Stockl' criticises the use of plots of difference against mean in the comparison of two methods of measurement, on the grounds that they assume a constant standard deviation over the range of the data. He recommends the use of regression instead. Our original papers on this topic-! started from the point that such studies were usually analysed by potentially misleading methods. These included correlation coefficients, regression testing the null hypothesis that the slope is one, and comparison of means only. Faced with data sets of this type we needed a more appropriate approach to the analysis, and developed an approach based on the difference between measurements by the two methods. The mean and standard deviation of these differences allow us to estimate the 95% limits of agreement, the values which the difference between measurements by the two methods would exceed on only 5% of occasions. This answered the clinical question: can we replace one method by the other and interpret the results in the same way?
Ann cu« Biochem 1997: 34 For this simple approach to work, the mean and standard deviation of the differences must be independent of the magnitude of the measurement. As a check on these assumptions, we recommended the plot of difference against mean. It was never intended as anything else, although we did think that if the assumptions were satisfied, adding the limits to the plot provided a neat graphical summary of the data.
The assumption of constant variation was usually good for the sort of data we were using, such as blood pressure, lung function, or cardiac stroke volume. For the data encountered in clinical biochemistry, the standard deviation is often proportional to the magnitude. The logarithmic transformation provides a way to remove this dependency and gives limits which are easily interpreted as ratios."
Regression has a place in the analysis of such data, particularly when the two methods compared give measurements which are not directly comparable (e.g. in different units), but it does not avoid the need for assumptions. For simple linear regression the standard deviation about the line must be uniform. The regression then gives us an estimate of the second measurement predicted from the first, with a 95% prediction interval. The latter depends on the magnitude of the first measurement, so is more complicated to use than the 95% limits of agreement.
In addition, as Hollis" notes, there is the important and implausible assumption that the x variable is measured without error. Only with this assumption can the intercept and slope be interpreted as constant and proportional error as Stockl l suggests. This deficiency of ordinary least squares regression in this context has been well recognized for some decades." If regression is used to analyse method comparison data, alternative models, which take explicit account of errors in both variables, are needed."
If the assumption of uniform standard deviation is not met, we must either use a transformation, or some more complex regression method which estimates both mean and standard deviation of the second measurement as functions of the first. This is a fairly difficult task, and we wanted something simple. Thus, for the comparison of measurement methods which we want to use interchangeably the 95% limits of agreement approach is preferable.
May we also take this opportunity to correct a small error in Hollis' otherwise excellent editorial?" It is not advisable to use the t
